Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	AIM2 inflammasome complex	CASP1 CARD16	6.23e-05	4	68	2	GO:0097169
GeneOntologyCellularComponent	IPAF inflammasome complex	CASP1 CARD16	6.23e-05	4	68	2	GO:0072557
GeneOntologyCellularComponent	phagophore assembly site	ATG7 PIK3C3 WIPI2	2.77e-04	39	68	3	GO:0000407
GeneOntologyCellularComponent	protease inhibitor complex	CASP1 CARD16	2.88e-04	8	68	2	GO:0097179
GeneOntologyCellularComponent	NLRP3 inflammasome complex	CASP1 CARD16	2.88e-04	8	68	2	GO:0072559
GeneOntologyCellularComponent	peptidase inhibitor complex	CASP1 CARD16	5.63e-04	11	68	2	GO:1904090
GeneOntologyCellularComponent	PML body	GCNA ZNF451 KAT6A ZMYM2	7.38e-04	125	68	4	GO:0016605
Domain	-	KLHL2 KLHL36 KLHL21	1.27e-04	27	68	3	2.130.10.80
Domain	Gal_Oxidase_b-propeller	KLHL2 KLHL36 KLHL21	2.55e-04	34	68	3	IPR015916
Domain	EGF_1	NELL2 EYS FN1 DLL4 UMODL1 NAGPA	3.29e-04	255	68	6	PS00022
Domain	EGF-like_CS	NELL2 EYS FN1 DLL4 UMODL1 NAGPA	3.73e-04	261	68	6	IPR013032
Domain	ASX_HYDROXYL	NELL2 EYS DLL4 UMODL1	4.85e-04	100	68	4	PS00010
Domain	BTB-kelch_protein	KLHL2 KLHL36 KLHL21	5.13e-04	43	68	3	IPR017096
Domain	EGF-type_Asp/Asn_hydroxyl_site	NELL2 EYS DLL4 UMODL1	6.04e-04	106	68	4	IPR000152
Domain	EGF_CA	NELL2 EYS DLL4 UMODL1	1.02e-03	122	68	4	SM00179
Domain	EGF-like_Ca-bd_dom	NELL2 EYS DLL4 UMODL1	1.09e-03	124	68	4	IPR001881
Domain	Kelch	KLHL2 KLHL36 KLHL21	1.23e-03	58	68	3	SM00612
Domain	-	ZYG11A TERB1 APC TAF6 TNPO3	1.29e-03	222	68	5	1.25.10.10
Domain	Gal_Oxase/kelch_b-propeller	KLHL2 KLHL36 KLHL21	1.30e-03	59	68	3	IPR011043
Domain	BACK	KLHL2 KLHL36 KLHL21	1.36e-03	60	68	3	SM00875
Domain	EGF_extracell	NELL2 DLL4 NAGPA	1.36e-03	60	68	3	IPR013111
Domain	EGF_2	NELL2 DLL4 NAGPA	1.36e-03	60	68	3	PF07974
Domain	BACK	KLHL2 KLHL36 KLHL21	1.43e-03	61	68	3	PF07707
Domain	BACK	KLHL2 KLHL36 KLHL21	1.43e-03	61	68	3	IPR011705
Domain	ARM-type_fold	ZYG11A PIK3C3 TERB1 APC TAF6 TNPO3	1.45e-03	339	68	6	IPR016024
Domain	CARD	CASP1 CARD16	1.52e-03	16	68	2	SM00114
Domain	EGF_3	NELL2 EYS DLL4 UMODL1 NAGPA	1.65e-03	235	68	5	PS50026
Domain	EGF	NELL2 EYS DLL4 UMODL1 NAGPA	1.65e-03	235	68	5	SM00181
Domain	Kelch_1	KLHL2 KLHL36 KLHL21	2.12e-03	70	68	3	PF01344
Domain	Kelch_1	KLHL2 KLHL36 KLHL21	2.12e-03	70	68	3	IPR006652
Domain	EGF-like_dom	NELL2 EYS DLL4 UMODL1 NAGPA	2.13e-03	249	68	5	IPR000742
Domain	VWC_out	NELL2 MUC5B	2.15e-03	19	68	2	SM00215
Domain	Growth_fac_rcpt_	NELL2 EYS DLL4 UMODL1	2.52e-03	156	68	4	IPR009030
Domain	EGF_2	NELL2 EYS DLL4 UMODL1 NAGPA	2.79e-03	265	68	5	PS01186
Domain	ARM-like	ZYG11A TERB1 APC TAF6 TNPO3	3.02e-03	270	68	5	IPR011989
Domain	HR1_rho-bd	RTKN2 TBC1D4	3.71e-03	25	68	2	IPR011072
Domain	BTB	KLHL2 KLHL36 KLHL21 KCNB2	4.21e-03	180	68	4	SM00225
Domain	PH_dom-like	RTKN2 TBC1D4 RASA3 SBF2 RABGAP1 ARHGEF15	4.52e-03	426	68	6	IPR011993
Domain	BTB/POZ_dom	KLHL2 KLHL36 KLHL21 KCNB2	4.63e-03	185	68	4	IPR000210
Domain	PID	TBC1D4 RABGAP1	4.64e-03	28	68	2	PF00640
Domain	CARD	CASP1 CARD16	4.64e-03	28	68	2	PF00619
Domain	VWC	NELL2 MUC5B	4.64e-03	28	68	2	PF00093
Domain	SKP1/BTB/POZ	KLHL2 KLHL36 KLHL21 KCNB2	5.00e-03	189	68	4	IPR011333
Domain	EGF_Ca-bd_CS	NELL2 EYS UMODL1	5.33e-03	97	68	3	IPR018097
Domain	EGF_CA	NELL2 EYS UMODL1	5.64e-03	99	68	3	PS01187
Domain	CARD	CASP1 CARD16	5.67e-03	31	68	2	IPR001315
Domain	PID	TBC1D4 RABGAP1	6.04e-03	32	68	2	PS01179
Domain	CARD	CASP1 CARD16	6.41e-03	33	68	2	PS50209
Pubmed	HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers.	ATG7 PIK3C3 CASP1	5.95e-07	9	68	3	29558368
Pubmed	Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth.	ATG7 APC	3.77e-06	2	68	2	26214133
Pubmed	Autophagy in the intestinal epithelium is not involved in the pathogenesis of intestinal tumors.	ATG7 APC	3.77e-06	2	68	2	22546555
Pubmed	Delta-like 4/Notch signaling promotes Apc Min/+ tumor initiation through angiogenic and non-angiogenic related mechanisms.	DLL4 APC	3.77e-06	2	68	2	28086833
Pubmed	LncRNA ADAMTS9-AS2 regulates periodontal ligament cell migration under mechanical compression via ADAMTS9/fibronectin.	FN1 ADAMTS9	1.13e-05	3	68	2	37957805
Pubmed	Miro-dependent mitochondrial pool of CENP-F and its farnesylated C-terminal domain are dispensable for normal development in mice.	CENPF RHOT1	1.13e-05	3	68	2	30856164
Pubmed	Mitotic redistribution of the mitochondrial network by Miro and Cenp-F.	CENPF RHOT1	1.13e-05	3	68	2	26259702
Pubmed	MUC5B mucin production is upregulated by fibronectin and laminin in human lung epithelial cells via the integrin and ERK dependent pathway.	FN1 MUC5B	1.13e-05	3	68	2	26057585
Pubmed	APC binds the Miro/Milton motor complex to stimulate transport of mitochondria to the plasma membrane.	APC RHOT1	1.13e-05	3	68	2	26658612
Pubmed	Deletion of PIK3C3/Vps34 in sensory neurons causes rapid neurodegeneration by disrupting the endosomal but not the autophagic pathway.	ATG7 PIK3C3	1.13e-05	3	68	2	20439739
Pubmed	Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing.	CASP1 CARD16	2.25e-05	4	68	2	11432859
Pubmed	Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors.	CASP1 CCR7	2.25e-05	4	68	2	38870946
Pubmed	Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells.	CASP1 APC	2.25e-05	4	68	2	25036629
Pubmed	ERK activation drives intestinal tumorigenesis in Apc(min/+) mice.	CASP1 APC	2.25e-05	4	68	2	20473309
Pubmed	Mutations of candidate tumor suppressor genes at chromosome 3p in intrahepatic cholangiocarcinoma.	ATG7 CACNA2D3	3.75e-05	5	68	2	29122566
Pubmed	Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins.	CASP1 CARD16	3.75e-05	5	68	2	11536016
Pubmed	Keratin 8-deletion induced colitis predisposes to murine colorectal cancer enforced by the inflammasome and IL-22 pathway.	CASP1 APC	3.75e-05	5	68	2	27234655
Pubmed	Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice.	ATG7 CASP1	3.75e-05	5	68	2	32400277
Pubmed	Inflammasomes within Hyperactive Murine Dendritic Cells Stimulate Long-Lived T Cell-Mediated Anti-tumor Immunity.	CASP1 CCR7	5.62e-05	6	68	2	33207188
Pubmed	Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis.	CASP1 APC	5.62e-05	6	68	2	24412611
Pubmed	PtdIns5P regulation through evolution: roles in membrane trafficking?	PIK3C3 SBF2	5.62e-05	6	68	2	18774718
Pubmed	INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation.	CASP1 CARD16	5.62e-05	6	68	2	15383541
Pubmed	LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesis.	BPTF APC	5.62e-05	6	68	2	30224759
Pubmed	Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation.	FN1 DLL4 ADAMTS9	5.74e-05	38	68	3	29743679
Pubmed	Update on the Kelch-like (KLHL) gene family.	KLHL2 KLHL36 KLHL21	7.23e-05	41	68	3	23676014
Pubmed	PtdIns(3)P-bound UVRAG coordinates Golgi-ER retrograde and Atg9 transport by differential interactions with the ER tether and the beclin 1 complex.	ATG7 PIK3C3	7.86e-05	7	68	2	24056303
Pubmed	Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy.	CENPF APC	1.05e-04	8	68	2	24823640
Pubmed	Protective role of Cop in Rip2/caspase-1/caspase-4-mediated HeLa cell death.	CASP1 CARD16	1.34e-04	9	68	2	16920334
Pubmed	PDPK1 regulates autophagosome biogenesis by binding to PIK3C3.	PIK3C3 WIPI2	1.34e-04	9	68	2	32876514
Pubmed	The N-Degron Pathway Mediates ER-phagy.	PIK3C3 WIPI2	1.34e-04	9	68	2	31375263
Pubmed	Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome.	DLL4 ADAMTS9	1.34e-04	9	68	2	23095891
Pubmed	PI(5)P regulates autophagosome biogenesis.	PIK3C3 WIPI2	1.68e-04	10	68	2	25578879
Pubmed	LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer's Disease.	ATG7 PIK3C3	1.68e-04	10	68	2	31257024
Pubmed	Select autophagy genes maintain quiescence of tissue-resident macrophages and increase susceptibility to Listeria monocytogenes.	ATG7 CASP1	1.68e-04	10	68	2	31959973
Pubmed	CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis.	CASP1 CARD16	1.68e-04	10	68	2	11821383
Pubmed	Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases.	KLHL36 KLHL21	2.05e-04	11	68	2	14528312
Pubmed	Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2.	ATG7 PIK3C3	2.05e-04	11	68	2	24141421
Pubmed	IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine.	CASP1 APC	2.05e-04	11	68	2	23075849
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	DHX15 UMODL1 KAT6A TNPO3 GAREM1	2.36e-04	283	68	5	18854154
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	FAM171A1 TBC1D4 PIK3C3 APC TMEM102 GEN1 TNPO3 PALLD	2.72e-04	861	68	8	36931259
Pubmed	A phospho/methyl switch at histone H3 regulates TFIID association with mitotic chromosomes.	BPTF TAF6	2.90e-04	13	68	2	20953165
Pubmed	3D biomimetic platform reveals the first interactions of the embryo and the maternal blood vessels.	FN1 DLL4	2.90e-04	13	68	2	34741805
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HEXA RASA3 KLHL36 KLHL21 SBF2 KAT6A BAHD1 TNPO3 GAREM1	2.93e-04	1105	68	9	35748872
Pubmed	A targeted mutation of Nkd1 impairs mouse spermatogenesis.	FN1 APC	3.38e-04	14	68	2	15546883
Pubmed	Host-Protozoan Interactions Protect from Mucosal Infections through Activation of the Inflammasome.	APC CCR7	3.38e-04	14	68	2	27716507
Pubmed	Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome.	FN1 ADAMTS9	3.38e-04	14	68	2	27687499
Pubmed	Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli.	FN1 DLL4	3.89e-04	15	68	2	19087347
Pubmed	Expression profiling of mouse subplate reveals a dynamic gene network and disease association with autism and schizophrenia.	FN1 CACNA2D3	3.89e-04	15	68	2	23401504
Pubmed	LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance.	ATG7 PIK3C3	3.89e-04	15	68	2	30245008
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ADAMTS9 SBF2 SCAPER PALLD ARHGEF15 C2CD5	4.10e-04	493	68	6	15368895
Pubmed	Hemodynamic Forces Sculpt Developing Heart Valves through a KLF2-WNT9B Paracrine Signaling Axis.	FN1 WNT9B	4.44e-04	16	68	2	29056552
Pubmed	Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice.	GEN1 CACNA2D3	4.44e-04	16	68	2	16096065
Pubmed	A ZFYVE21-Rubicon-RNF34 signaling complex promotes endosome-associated inflammasome activity in endothelial cells.	CASP1 CARD16	4.44e-04	16	68	2	37225719
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TBC1D4 CENPF APC ZMYM2 TAF6 PALLD	4.56e-04	503	68	6	16964243
Pubmed	Temporal requirements for ISL1 in sympathetic neuron proliferation, differentiation, and diversification.	CENPF DLL4 KCNB2	4.71e-04	77	68	3	29445148
Pubmed	Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes.	BPTF TAF6	5.03e-04	17	68	2	21653943
Pubmed	Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo.	ATG7 PIK3C3	5.03e-04	17	68	2	25327288
Pubmed	Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos.	FN1 DLL4	5.03e-04	17	68	2	18559979
Pubmed	USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier.	BPTF TAF6	5.65e-04	18	68	2	17846119
Pubmed	Genetically distinct subsets within ANCA-associated vasculitis.	WNT9B PCDH11X	5.65e-04	18	68	2	22808956
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BPTF TBC1D4 TTLL3 ATG7 RASA3 PIK3C3 SBF2 KAT6A RABGAP1 TARS2	6.07e-04	1489	68	10	28611215
Pubmed	Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.	FN1 APC	6.30e-04	19	68	2	30760929
Pubmed	A ubiquitin-based effector-to-inhibitor switch coordinates early brain, craniofacial, and skin development.	KLHL2 KLHL36 KLHL21	6.74e-04	87	68	3	37495603
Pubmed	BMP-Responsive Protease HtrA1 Is Differentially Expressed in Astrocytes and Regulates Astrocytic Development and Injury Response.	FN1 APC	7.00e-04	20	68	2	29483282
Pubmed	CBAP functions as a novel component in chemokine-induced ZAP70-mediated T-cell adhesion and migration.	CCR7 TMEM102	7.00e-04	20	68	2	23620790
Pubmed	The molecular anatomy of mammalian upper lip and primary palate fusion at single cell resolution.	ADAMTS9 WNT9B	7.00e-04	20	68	2	31118233
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TBC1D4 APC PALLD WIPI2	7.64e-04	209	68	4	36779422
Pubmed	Immunomic analysis of human sarcoma.	TBC1D4 PALLD	7.72e-04	21	68	2	12601173
Pubmed	DLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport.	FN1 DLL4	7.72e-04	21	68	2	26529256
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	DHX15 BPTF ATG7 ZNF451 CASP1 RABGAP1 TAF6 MYO15A	7.99e-04	1014	68	8	32416067
Pubmed	The ER-Localized Transmembrane Protein EPG-3/VMP1 Regulates SERCA Activity to Control ER-Isolation Membrane Contacts for Autophagosome Formation.	PIK3C3 WIPI2	8.48e-04	22	68	2	28890335
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	DHX15 HEXA BPTF NSUN5 TBC1D4 PIK3C3 APC TNPO3 PALLD	9.25e-04	1297	68	9	33545068
Pubmed	Secreted metalloproteases ADAMTS9 and ADAMTS20 have a non-canonical role in ciliary vesicle growth during ciliogenesis.	FN1 ADAMTS9	9.28e-04	23	68	2	30814516
Pubmed	Meiotic gatekeeper STRA8 suppresses autophagy by repressing Nr1d1 expression during spermatogenesis in mice.	ATG7 PIK3C3	9.28e-04	23	68	2	31059511
Pubmed	ADAMTS9-Mediated Extracellular Matrix Dynamics Regulates Umbilical Cord Vascular Smooth Muscle Differentiation and Rotation.	FN1 ADAMTS9	9.28e-04	23	68	2	26027930
Pubmed	Myocardial Angiopoietin-1 Controls Atrial Chamber Morphogenesis by Spatiotemporal Degradation of Cardiac Jelly.	DLL4 ADAMTS9	1.01e-03	24	68	2	29791855
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	TBC1D4 ZNF451 C2CD5	1.16e-03	105	68	3	9628581
Pubmed	Reconstruction of phrenic neuron identity in embryonic stem cell-derived motor neurons.	DLL4 PCDH11X	1.28e-03	27	68	2	24496616
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TBC1D4 CENPF APC ZMYM2 RABGAP1	1.37e-03	418	68	5	34709266
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	BPTF NELL2 KLHL21 KAT6A SCAPER TAF6 C2CD5 RHOT1	1.47e-03	1116	68	8	31753913
Pubmed	Interrogating translational efficiency and lineage-specific transcriptomes using ribosome affinity purification.	DLL4 ARHGEF15	1.48e-03	29	68	2	24003143
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	DHX15 BPTF CENPF APC	1.48e-03	250	68	4	33536335
Pubmed	Overactive Wnt5a signaling disrupts hair follicle polarity during mouse skin development.	FN1 WNT9B	1.58e-03	30	68	2	36305473
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	DHX15 TBC1D4 PIK3C3 TMEM102	1.59e-03	255	68	4	15324660
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	DHX15 ZNF451 ZMYM2 TAF6 PALLD	1.79e-03	444	68	5	34795231
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	DHX15 KLHL2 RTKN2 DCAF10 CENPF ZNF451 APC ZMYM2	1.83e-03	1155	68	8	20360068
Interaction	ZNF726 interactions	ZNF430 DCAF10 TRIM39	7.91e-06	12	68	3	int:ZNF726
Cytoband	1p36.31	KLHL21 RNF207	1.94e-04	14	68	2	1p36.31
GeneFamily	Kelch like\|BTB domain containing	KLHL2 KLHL36 KLHL21	1.76e-04	42	47	3	617
GeneFamily	Calcium voltage-gated channel subunits	CACNA1G CACNA2D3	2.07e-03	26	47	2	253
GeneFamily	WD repeat domain containing\|Caspase recruitment domain containing\|Apoptosome	CASP1 CARD16	2.75e-03	30	47	2	959
GeneFamily	Autophagy related	ATG7 WIPI2	3.32e-03	33	47	2	1022
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	KLHL2 KLHL36 KLHL21	5.09e-03	134	47	3	861
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	DHX15 FAM171A1 BPTF CENPF PIK3C3 KAT6A ZMYM2 RABGAP1 C2CD5	3.20e-06	466	68	9	M13522
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DHX15 FAM171A1 BPTF CENPF PIK3C3 ZNF451 KAT6A APC ZMYM2 RABGAP1 C2CD5	1.18e-05	856	68	11	M4500
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	NELL2 TBC1D4 RASA3 TTC9B FAM78B CCR7	1.45e-07	156	68	6	e308328f560c5ee7e9f95ac5db162f2d821ca39c
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EYS CENPF KLHL21 CACNA1G CCR7	2.33e-06	139	68	5	505bf5a483fc2ba69377db9850c3b26ab2f416d1
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tregs\|GI_small-bowel / Manually curated celltypes from each tissue	RTKN2 TBC1D4 CASP1 CARD16 CCR7	3.98e-06	155	68	5	d4ef25965a15eab7679478b9b661e1b4a92f1c59
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAM171A1 ADAMTS9 WNT9B TRIM39 ARHGEF15	5.73e-06	167	68	5	d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCell	severe-CD8+_T_naive\|severe / disease stage, cell group and cell class	ZNF430 NELL2 KLHL36 TRIM39 CCR7	8.24e-06	180	68	5	94fe530367b170777f4051a4034cff06d80dbb83
ToppCell	(1)_T_CD4_naive\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	RTKN2 NELL2 TBC1D4 RASA3 CCR7	1.02e-05	188	68	5	b8f67ac2faadd5b848955e43ab5d6cf5e49b3681
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAM171A1 CASP1 ATP10B GSTO2 RNF182	1.24e-05	196	68	5	055993612af03bff5ef73580a6402578da850df9
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RTKN2 SCAPER PCDH11X RNF207 FAAH	1.27e-05	197	68	5	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HEXA FN1 CASP1 CARD16 CACNA2D3	1.34e-05	199	68	5	639539d27e8ea1cc47630a69668e6cba02f8c9ca
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FAM171A1 FN1 DLL4 RABGAP1 ARHGEF15	1.37e-05	200	68	5	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FN1 DLL4 RABGAP1 PALLD ARHGEF15	1.37e-05	200	68	5	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	PND28-Immune-Immune_Myeloid-DC-maDC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NSUN5 TBC1D4 CCR7 PALLD	8.84e-05	153	68	4	b03375c54aa701817c0fc2c3fef32b870169e697
ToppCell	PND28-Immune-Immune_Myeloid-DC-maDC-maDC_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NSUN5 TBC1D4 CCR7 PALLD	8.84e-05	153	68	4	18bd770a18e642581a6df144d47184c1ac383713
ToppCell	CV-Healthy-3\|Healthy / Virus stimulation, Condition and Cluster	RTKN2 TBC1D4 KLHL21 FAAH	9.07e-05	154	68	4	26bf81a86700db7e65c2384ffe94ed4253ea4047
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RTKN2 TBC1D4 ZMYM2 CARD16	9.07e-05	154	68	4	b16f3139ce50e70a6a2377b1da7d7877b4000ea1
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_2\|367C / Donor, Lineage, Cell class and subclass (all cells)	RTKN2 TBC1D4 ZMYM2 CARD16	9.77e-05	157	68	4	f1c6c313836352271033d23efd31b0f0a8a09e02
ToppCell	severe_influenza-CD4+_T_naive\|World / disease group, cell group and cell class (v2)	NELL2 TBC1D4 CCR7 MYO15A	1.00e-04	158	68	4	8ab3d8a9b7a1daa890d76dde1d6182af40b70021
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-Tregs\|Lung / Manually curated celltypes from each tissue	RTKN2 TBC1D4 CCR7 RNF207	1.00e-04	158	68	4	f433bc189f000efa34e8e09ab32b3fa22bcf64c4
ToppCell	Int-URO-Lymphocyte-T_NK-Treg\|Int-URO / Disease, Lineage and Cell Type	RTKN2 TBC1D4 UMODL1 CCR7	1.00e-04	158	68	4	457d64dceedb67bfff1303334cda1253a839b3d6
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FN1 FAM78B CHML FAAH	1.03e-04	159	68	4	210ac7fa89514a84f38d9f42254e38fbc2bc5f42
ToppCell	Adult-Endothelial-endothelial_cell_of_vein-D122\|Adult / Lineage, Cell type, age group and donor	FAM171A1 UMODL1 WNT9B ARHGEF15	1.05e-04	160	68	4	0cfe130606af433b2aa90e0a20b6c44659dd6fd4
ToppCell	CV-Healthy-3\|CV / Virus stimulation, Condition and Cluster	RTKN2 TBC1D4 KLHL21 FAAH	1.08e-04	161	68	4	fd4a79385ea967b9900dc76a3add813b894a3a28
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	NELL2 RASA3 CCR7 FAAH	1.18e-04	165	68	4	ecaeb90a6bc27524ef6f2eefa72aec7315dbde3b
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FAM171A1 ADAMTS9 WNT9B ARHGEF15	1.21e-04	166	68	4	f7926ee266dcbf10df375cd921f1db5a2fa604f8
ToppCell	systemic_lupus_erythematosus-flare-Hematopoietic-Progen-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RTKN2 NELL2 UMODL1 CCR7	1.24e-04	167	68	4	b89ebd4906f52b1fe6b6540ec9339284e7caddd2
ToppCell	droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM171A1 NSUN5 ADAMTS9 TARS2	1.27e-04	168	68	4	2201ae834b53cbdc085f8f02607fa5b5bd911268
ToppCell	356C-Myeloid-Dendritic-cDC_activated\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TBC1D4 FAM78B CCR7 RNF207	1.30e-04	169	68	4	44d201361eb497222a4972a0e10bac1e05dcfd0a
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZYG11A CASP1 CARD16 CACNA2D3	1.33e-04	170	68	4	3e52d40b0c36ab5b627a2dad025248901af8a320
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NELL2 TTC9B PCDH11X KCNB2	1.36e-04	171	68	4	9d5cabd71a901a00eb16c4d151189296f1b3bf6f
ToppCell	Adult-Endothelial-endothelial_cell_of_bronchial_vessel\|Adult / Lineage, Cell type, age group and donor	FAM171A1 DLL4 ADAMTS9 ARHGEF15	1.39e-04	172	68	4	ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6
ToppCell	Mesenchymal_cells-Osteo-CAR\|Mesenchymal_cells / Lineage and Cell class	ADAMTS9 FAM78B PALLD RNF182	1.45e-04	174	68	4	430e3cd61bc2a471959faa40e817aa4dd7d82d28
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 DLL4 PCDH11X ARHGEF15	1.58e-04	178	68	4	5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NELL2 TTC9B PCDH11X KCNB2	1.58e-04	178	68	4	731e1e8eff2c4018c75dfc66632a316010a09a9a
ToppCell	severe-CD8+_T_naive\|World / disease stage, cell group and cell class	ZNF430 KLHL36 TRIM39 CCR7	1.69e-04	181	68	4	69eeeb7f326e230b07495d557f708fbe3312ac0a
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RTKN2 TBC1D4 PKD1L1 C2CD5	1.76e-04	183	68	4	f142b320023eef00b48d4820c46214c9794d37e7
ToppCell	(1)_T_cells-(1)_T_regulatory\|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	RTKN2 TBC1D4 FAM78B CARD16	1.80e-04	184	68	4	3cbf81757653652441843d85cb7ec1dcf25ca1b0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NELL2 TBC1D4 RASA3 CCR7	1.80e-04	184	68	4	bd786db4dc4edae6d5cfc0b69901983dea19f729
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	RTKN2 PKD1L1 C2CD5 RHOT1	1.83e-04	185	68	4	e06a784a297f357f3f8e761c24fa70722048ab42
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RTKN2 CENPF MUC5B TAF6	1.83e-04	185	68	4	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NELL2 TBC1D4 RASA3 CCR7	1.83e-04	185	68	4	847257d232b9993cad50c814fd4ffeef52385295
ToppCell	normal_Lung-T/NK_cells-Treg\|T/NK_cells / Location, Cell class and cell subclass	RTKN2 TBC1D4 FAM78B CARD16	1.83e-04	185	68	4	ea416362d3f06b4a0a7f08c2e5dbbc864f121555
ToppCell	PBMC-Control-cDC_10\|Control / Compartment, Disease Groups and Clusters	TBC1D4 FAM78B CCR7 RNF207	1.83e-04	185	68	4	4b5a7450fed912f340da16065c1e65d626dbe8d1
ToppCell	Mesenchymal_cells-Osteo-CAR\|World / Lineage and Cell class	ADAMTS9 FAM78B PALLD RNF182	1.83e-04	185	68	4	16f1588893d09c864e0cb4f837a1b972a1a57baa
ToppCell	droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH11X CACNA1G PALLD CACNA2D3	1.87e-04	186	68	4	b58db5abdd3e9f0214b198c3cbd09b0b3c321eab
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined\|Fibroblasts / Location, Cell class and cell subclass	DCAF10 KLHL36 TARS2 WIPI2	1.87e-04	186	68	4	403ac98f72a42721f84fbd7826f251a88ae534a2
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH11X CACNA1G PALLD CACNA2D3	1.87e-04	186	68	4	cd6502bbf9dce318fdbb4965d49df8951e5f795c
ToppCell	Adult-Endothelial-endothelial_cell_of_artery\|Adult / Lineage, Cell type, age group and donor	FAM171A1 DLL4 WNT9B PCDH11X	1.87e-04	186	68	4	2d1c4ea2e401db89971582ee54618a8b0c81b8ac
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAM171A1 ADAMTS9 WNT9B ARHGEF15	1.91e-04	187	68	4	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	metastatic_Brain-T/NK_cells-Treg\|metastatic_Brain / Location, Cell class and cell subclass	RTKN2 TBC1D4 CASP1 CARD16	1.91e-04	187	68	4	1b88e1399809c50a0156096d9c82b1d9e58bb720
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RTKN2 RNF207 CACNA2D3 GAREM1	1.91e-04	187	68	4	ff26a533d310126521efe1d05cf8b9d32e524550
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCDH11X CACNA1G PALLD CACNA2D3	1.91e-04	187	68	4	8bd635abdee5d5a12a3f7bf74eab4282e8e40741
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCDH11X CACNA1G PALLD CACNA2D3	1.91e-04	187	68	4	3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0
ToppCell	VE-Treg-CD4_Treg\|VE / Condition, Cell_class and T cell subcluster	RTKN2 TBC1D4 CASP1 CARD16	1.95e-04	188	68	4	fa88ceb336e30de3585e62608527a0d44df74190
ToppCell	VE-Treg\|VE / Condition, Cell_class and T cell subcluster	RTKN2 TBC1D4 CASP1 CARD16	1.95e-04	188	68	4	ef048517dfe2fc995d13eb1f08106a487354a4cc
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 DLL4 PCDH11X ARHGEF15	2.03e-04	190	68	4	bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_Tregs\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RTKN2 TBC1D4 CASP1 CARD16	2.03e-04	190	68	4	f69a4733b5d1542ab4d0eb44856f2c5c34c18b9e
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	DHX15 PIK3C3 TAF6 BAHD1	2.03e-04	190	68	4	2434b8ad2976eab7d9147012c28454ab29670709
ToppCell	COVID-19-Heart-EC_3\|Heart / Disease (COVID-19 only), tissue and cell type	KLHL2 ADAMTS9 WNT9B ARHGEF15	2.03e-04	190	68	4	78e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCell	metastatic_Lymph_Node-T/NK_cells-Treg\|metastatic_Lymph_Node / Location, Cell class and cell subclass	RTKN2 TBC1D4 FAM78B CARD16	2.03e-04	190	68	4	0523f1039b39a45a23f2f4444e5b47ed581fc4bb
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	TBC1D4 RNF207 PALLD CACNA2D3	2.03e-04	190	68	4	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	(3)_MNP-(3)_DC_activated\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	NELL2 TBC1D4 CCR7 PALLD	2.07e-04	191	68	4	0353bf797c4ef237b9bb82460c173c7d03cb8883
ToppCell	ILEUM-non-inflamed-(1)_Tregs\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RTKN2 TBC1D4 CASP1 CARD16	2.07e-04	191	68	4	e065d16a1f88c91dec576d248a318534ceab1cb2
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NELL2 TTC9B FAM78B RNF182	2.07e-04	191	68	4	73b15ffa60d592c43aaa575f1b1479d49a66dfe8
ToppCell	CV-Mild-5\|CV / Virus stimulation, Condition and Cluster	RTKN2 NELL2 TBC1D4 CCR7	2.07e-04	191	68	4	cf40d2b3daeb968b05b4dc2a0a9dc3eb9a0cccfa
ToppCell	normal_Lymph_Node-T/NK_cells-Treg\|normal_Lymph_Node / Location, Cell class and cell subclass	RTKN2 TBC1D4 CASP1 CARD16	2.11e-04	192	68	4	d2c2a98d331522a3ab7973bfaf4396ef4d684888
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 DLL4 ADAMTS9 ARHGEF15	2.11e-04	192	68	4	0aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCell	COVID-19_Moderate-CD4+_T_activated\|COVID-19_Moderate / disease group, cell group and cell class	RTKN2 NELL2 TBC1D4 CCR7	2.11e-04	192	68	4	7a81652406332afd03a9b3b529e9b5e6c0b54c28
ToppCell	metastatic_Brain-T/NK_cells-Treg\|T/NK_cells / Location, Cell class and cell subclass	RTKN2 TBC1D4 CASP1 CARD16	2.11e-04	192	68	4	7c6f44716fc684b0297f266f04968e26fabdf6e3
ToppCell	ILEUM-inflamed-(1)_Tregs\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RTKN2 TBC1D4 CASP1 CARD16	2.11e-04	192	68	4	1fe3417dfd1cf1758fd82c9ac13dbd88bdf0b548
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 DLL4 PCDH11X ARHGEF15	2.11e-04	192	68	4	56b021c297a21dff357531f21e2464f85186106d
ToppCell	COVID-19_Moderate-CD4+_T_activated\|World / disease group, cell group and cell class	RTKN2 NELL2 TBC1D4 CCR7	2.16e-04	193	68	4	c2a2a2c14a7085690262db5c2a70e38db67dee18
ToppCell	tumor_Lung-T/NK_cells-Treg\|tumor_Lung / Location, Cell class and cell subclass	RTKN2 TBC1D4 CASP1 CARD16	2.16e-04	193	68	4	675645fb2e8e75fedba2ab51f67200961bfd2436
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	BPTF DCAF10 SBF2 CHML	2.16e-04	193	68	4	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 SBF2 KAT6A ARHGEF15	2.16e-04	193	68	4	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 SBF2 KAT6A ARHGEF15	2.16e-04	193	68	4	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	CV-Mild-5\|Mild / Virus stimulation, Condition and Cluster	RTKN2 NELL2 TBC1D4 CCR7	2.16e-04	193	68	4	2053f0f8083b3174e1b6f76d2d7089f59982565d
ToppCell	tumor_Lung-Endothelial_cells-Stalk-like_ECs\|tumor_Lung / Location, Cell class and cell subclass	FAM171A1 DLL4 ADAMTS9 ARHGEF15	2.16e-04	193	68	4	21fec35587ffb5c0157e54a821ce3ffd3e24e536
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	NELL2 TBC1D4 RASA3 CCR7	2.16e-04	193	68	4	772e0370bda4bffed7798b8714e32c9e2a1d9b67
ToppCell	normal_Lymph_Node-T/NK_cells-Treg\|T/NK_cells / Location, Cell class and cell subclass	RTKN2 TBC1D4 CASP1 CARD16	2.16e-04	193	68	4	51fd629e91c85881c3231486d6d2fb2c65fcd77b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF430 RTKN2 ADAMTS9 GAREM1	2.20e-04	194	68	4	46070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF430 RTKN2 ADAMTS9 GAREM1	2.20e-04	194	68	4	abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	FN1 ADAMTS9 WNT9B PCDH11X	2.20e-04	194	68	4	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	IPF-Endothelial\|IPF / Disease state, Lineage and Cell class	FAM171A1 DLL4 ADAMTS9 ARHGEF15	2.20e-04	194	68	4	9591993aa2dcba3d09a0f1ea8b8f2439c26482d6
ToppCell	Endothelial-endothelial_cell_of_vein\|World / Lineage, Cell type, age group and donor	FAM171A1 ADAMTS9 WNT9B ARHGEF15	2.20e-04	194	68	4	3cbd9622a68e89add90e589867d88c83c5a33476
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Tregs\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RTKN2 TBC1D4 CASP1 CARD16	2.20e-04	194	68	4	0396457834bbfed8d0b9b2ddaaecd9f28e1d56ed
ToppCell	390C-Lymphocytic-CD4_T-cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RTKN2 NELL2 TBC1D4 CCR7	2.20e-04	194	68	4	76c4c3ba5f1bcc39d397c90db3513f5bea632b1b
ToppCell	Adult-Endothelial\|Adult / Lineage, Cell type, age group and donor	FAM171A1 DLL4 ADAMTS9 ARHGEF15	2.20e-04	194	68	4	963b3fbee0575af8379baa397ace65949eaf34f7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NELL2 TBC1D4 RASA3 CCR7	2.20e-04	194	68	4	a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2
ToppCell	tumor_Lung-T/NK_cells-Treg\|T/NK_cells / Location, Cell class and cell subclass	RTKN2 TBC1D4 CASP1 CARD16	2.24e-04	195	68	4	dd112ef3f8bd0790719827b6bb120918687afdff
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 DLL4 ADAMTS9 ARHGEF15	2.24e-04	195	68	4	56efeb58df19f357d7d5ce87348d4f196a595421
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	NELL2 TBC1D4 KAT6A CCR7	2.24e-04	195	68	4	4bdedd924564a260841a9153604026b57487c83d
ToppCell	(6)_Endothelial-D\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	FAM171A1 DLL4 ADAMTS9 ARHGEF15	2.24e-04	195	68	4	c0005a5f2dc63a0cc254c45ac89a2f42df6f8bde
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	FN1 PALLD RNF182 CACNA2D3	2.24e-04	195	68	4	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	RTKN2 NELL2 TBC1D4 CCR7	2.29e-04	196	68	4	ffc2728663a72ec62fa2e5b1054368fb56d18c62
ToppCell	Mild-CD4+_T_activated\|Mild / Disease group and Cell class	TBC1D4 CASP1 CARD16 CCR7	2.29e-04	196	68	4	daa1c3322d81e649161e889e1d78451d2d425d09
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RTKN2 PCDH11X RNF207 FAAH	2.33e-04	197	68	4	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	tumor_Lung-Endothelial_cells\|tumor_Lung / Location, Cell class and cell subclass	FAM171A1 DLL4 ADAMTS9 ARHGEF15	2.33e-04	197	68	4	6870b311c54a73723768276a58456620f5217d43
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD4+_T_naive\|COVID-19_Severe / Disease group, lineage and cell class	NELL2 TBC1D4 KLHL36 CCR7	2.33e-04	197	68	4	07f74bdadfd28e1d55b3f4a3bf87d5dd65a2e9c5
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-Treg\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RTKN2 TBC1D4 CARD16 CCR7	2.33e-04	197	68	4	a6eba89bb3e24ae973068f85a8bcc3094e985cb9
ToppCell	368C-Endothelial_cells-Endothelial-A_(Artery)\|368C / Donor, Lineage, Cell class and subclass (all cells)	FAM171A1 DLL4 ADAMTS9 ARHGEF15	2.33e-04	197	68	4	7caa2c86dc4d50b57a7db8f7278d1588282ad6db
Computational	Genes upregulated in subsets of cells of a given type within various tumors	RTKN2 TBC1D4 CASP1 CARD16	4.13e-05	49	43	4	GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_T_REG
Drug	AC1N0FHX	KAT6A CASP1 CARD16	1.41e-06	8	68	3	CID003916227
Drug	1rww	CASP1 CARD16	8.79e-06	2	68	2	CID005289080
Drug	Diphenyl Ether Sulfonamide 10	CASP1 CARD16	8.79e-06	2	68	2	CID009887536
Drug	Biphenyl Sulfonamide 1	CASP1 CARD16	8.79e-06	2	68	2	CID010449481
Drug	1rwx	CASP1 CARD16	8.79e-06	2	68	2	CID005289610
Drug	Diphenyl Ether Sulfonamide 2	CASP1 CARD16	8.79e-06	2	68	2	CID015888281
Drug	Diphenyl Ether Sulfonamide 9	CASP1 CARD16	8.79e-06	2	68	2	CID015888283
Drug	Diphenyl Ether Sulfonamide 5	CASP1 CARD16	8.79e-06	2	68	2	CID015888282
Drug	arylsulfonamide analogue 16	CASP1 CARD16	8.79e-06	2	68	2	CID015888284
Drug	Diphenyl Ether Sulfonamide 7	CASP1 CARD16	8.79e-06	2	68	2	CID015888286
Drug	arylsulfonamide analogue 11	CASP1 CARD16	8.79e-06	2	68	2	CID015888279
Drug	Diphenyl Ether Sulfonamide 12	CASP1 CARD16	8.79e-06	2	68	2	CID010070710
Drug	AC1NR9V6	CASP1 CARD16	8.79e-06	2	68	2	CID005287535
Drug	AAF-cmk	CASP1 CARD16	8.79e-06	2	68	2	CID006610326
Drug	Cyclo(lys-pro)	CASP1 CARD16	8.79e-06	2	68	2	CID000194922
Drug	AC1NRAF8	CASP1 CARD16	8.79e-06	2	68	2	CID005287849
Drug	Aa 31	CASP1 CARD16 CCR7	1.68e-05	17	68	3	CID000191056
Drug	Leucomisine [17946-87-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	FN1 RABGAP1 CHML TNPO3 WIPI2 FAAH	2.50e-05	194	68	6	6767_DN
Drug	Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A	FN1 RASA3 CENPF CASP1 APC RABGAP1	2.50e-05	194	68	6	3308_UP
Drug	Dabcyl-ice-edans	CASP1 CARD16	2.63e-05	3	68	2	CID005748518
Drug	AC1NBJ9O	CASP1 CARD16	2.63e-05	3	68	2	CID004468934
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	TBC1D4 FN1 CENPF SCAPER CASP1 APC	2.72e-05	197	68	6	5507_DN
Drug	Ceforanide [60925-61-3]; Up 200; 7.6uM; PC3; HT_HG-U133A	KAT6A CASP1 ATP10B CACNA1G CCR7 MYO15A	2.80e-05	198	68	6	6751_UP
Drug	Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A	FN1 CENPF APC ZMYM2 ATP10B CCR7	2.80e-05	198	68	6	4158_UP
Drug	5f-1	FN1 CASP1 CARD16	3.77e-05	22	68	3	CID015991535
Drug	AC1ODTZD	CASP1 CARD16	5.25e-05	4	68	2	CID007020821
Drug	AC1NUKW9	CASP1 CARD16	5.25e-05	4	68	2	CID005481610
Drug	cinchomeronate	CASP1 CARD16	5.25e-05	4	68	2	CID000010273
Drug	AC1L33DC	CASP1 CARD16 GSTO2	7.91e-05	28	68	3	CID000133757
Drug	hqc	CASP1 CARD16	8.74e-05	5	68	2	CID005288581
Drug	Oxeclosporin	CASP1 CARD16	8.74e-05	5	68	2	CID006436153
Drug	Ac-YVAD-pNA	CASP1 CARD16	8.74e-05	5	68	2	CID000004338
Drug	AC1N3S5K	CASP1 CARD16	8.74e-05	5	68	2	CID004117381
Drug	PBDA	FN1 CASP1 CARD16	9.76e-05	30	68	3	CID000004408
Drug	fenugreek seed meal	FN1 CASP1	1.31e-04	6	68	2	ctd:C056164
Drug	lavendustin A	PIK3C3 CASP1 CARD16 CACNA1G CACNA2D3	1.60e-04	171	68	5	CID000003894
Drug	N-Ac-Tyr-Val-Ala-Asp-chloromethyl ketone	CASP1 APC CARD16	1.70e-04	36	68	3	CID000003722
Drug	rupintrivir	CASP1 CARD16	1.83e-04	7	68	2	CID006440352
Drug	Isatin analog 1	CASP1 CARD16	1.83e-04	7	68	2	CID000515950
Drug	F1-G	CASP1 CARD16	1.83e-04	7	68	2	CID006852193
Drug	Inhibitor 47c	CASP1 CARD16	1.83e-04	7	68	2	CID005327301
Drug	Inhibitor 66b	CASP1 CARD16	1.83e-04	7	68	2	CID005327309
Drug	catalpol	CASP1 CARD16	1.83e-04	7	68	2	CID000091520
Drug	bestatin methyl ester	CASP1 CARD16	2.43e-04	8	68	2	CID009927170
Drug	Ac-wehd-cho	CASP1 CARD16	2.43e-04	8	68	2	CID005311140
Drug	hydrochalcone	CASP1 CARD16	2.43e-04	8	68	2	CID000064802
Drug	Isatin Sulfonamide 26	CASP1 CARD16	2.43e-04	8	68	2	CID009800285
Drug	M-IBDET	CASP1 CARD16	2.43e-04	8	68	2	CID005464042
Drug	denitro-nipradilol	CASP1 CARD16	2.43e-04	8	68	2	CID000135168
Drug	Isatin analog 2	CASP1 CARD16	2.43e-04	8	68	2	CID010826725
Drug	AC1L2A54	HEXA ATG7 CASP1 CARD16 TRIM39	2.68e-04	191	68	5	CID000068636
Drug	Propofol [2078-54-8]; Down 200; 22.4uM; MCF7; HT_HG-U133A	RASA3 SCAPER APC RABGAP1 BAHD1	2.68e-04	191	68	5	3386_DN
Drug	PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A	FN1 APC MUC5B MYO15A WIPI2	2.88e-04	194	68	5	6368_UP
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A	FN1 SCAPER CASP1 RABGAP1 CHML	2.88e-04	194	68	5	4141_DN
Drug	Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	FN1 ZMYM2 RABGAP1 CHML GAREM1	2.88e-04	194	68	5	7479_DN
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A	CENPF SCAPER CASP1 APC WIPI2	2.88e-04	194	68	5	3384_DN
Drug	Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; HL60; HG-U133A	DHX15 CENPF CASP1 RABGAP1 TARS2	2.88e-04	194	68	5	1741_DN
Drug	0393-0188; Up 200; 10uM; MCF7; HT_HG-U133A	CENPF SCAPER CASP1 CHML WIPI2	2.95e-04	195	68	5	7531_UP
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	CENPF KAT6A CASP1 APC MUC5B	3.02e-04	196	68	5	5230_UP
Drug	Edrophonium chloride [116-38-1]; Up 200; 19.8uM; PC3; HT_HG-U133A	RASA3 APC RABGAP1 CHML ARHGEF15	3.02e-04	196	68	5	6655_UP
Drug	Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A	NELL2 RASA3 CENPF ZMYM2 RABGAP1	3.02e-04	196	68	5	2236_UP
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A	CENPF KAT6A APC ATP10B BAHD1	3.02e-04	196	68	5	3762_DN
Drug	NS-398; Up 200; 10uM; MCF7; HT_HG-U133A	KLHL2 ADAMTS9 CASP1 APC BAHD1	3.02e-04	196	68	5	6911_UP
Drug	Terconazole [67915-31-5]; Up 200; 7.6uM; HL60; HT_HG-U133A	NELL2 FN1 KLHL36 ATP10B MYO15A	3.02e-04	196	68	5	2484_UP
Drug	Amidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A	FAM171A1 NELL2 FN1 CASP1 MUC5B	3.09e-04	197	68	5	2222_UP
Drug	Sulfamerazine [127-79-7]; Up 200; 15.2uM; HL60; HT_HG-U133A	FAM171A1 RASA3 KAT6A NAGPA GAREM1	3.09e-04	197	68	5	2181_UP
Drug	Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ZNF430 KLHL2 CHML FAAH GAREM1	3.09e-04	197	68	5	6017_DN
Drug	thiazepine	CASP1 CARD16	3.12e-04	9	68	2	CID012444276
Drug	Isatin Sulfonamide 29	CASP1 CARD16	3.12e-04	9	68	2	CID009821545
Drug	CpMn	CASP1 CARD16	3.12e-04	9	68	2	CID000146199
Drug	Ho Chi	CASP1 CARD16	3.12e-04	9	68	2	CID000128142
Drug	caprolactam	CASP1 CARD16	3.12e-04	9	68	2	CID000007768
Drug	Inhibitor 69b	CASP1 CARD16	3.12e-04	9	68	2	CID005327310
Drug	inhibitor 59	CASP1 CARD16	3.12e-04	9	68	2	CID005327305
Drug	Inhibitor 66a	CASP1 CARD16	3.12e-04	9	68	2	CID005327308
Drug	Inhibitor 64b	CASP1 CARD16	3.12e-04	9	68	2	CID005327307
Drug	AC1NS22C	CASP1 CARD16	3.12e-04	9	68	2	CID005327306
Drug	SA981	CASP1 CARD16	3.12e-04	9	68	2	CID000054805
Drug	Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; MCF7; HT_HG-U133A	NELL2 FN1 RASA3 SCAPER ATP10B	3.16e-04	198	68	5	5983_UP
Drug	Etodolac [41340-25-4]; Down 200; 14uM; MCF7; HT_HG-U133A	KLHL21 CASP1 TARS2 NAGPA BAHD1	3.16e-04	198	68	5	7006_DN
Drug	Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	FN1 KLHL21 KAT6A BAHD1 GAREM1	3.16e-04	198	68	5	7415_DN
Drug	butein; Down 200; 10uM; MCF7; HG-U133A	TBC1D4 FN1 ATP10B TNPO3 GAREM1	3.16e-04	198	68	5	607_DN
Drug	Nadolol [42200-33-9]; Down 200; 13uM; MCF7; HT_HG-U133A	NELL2 FN1 CASP1 RABGAP1 MYO15A	3.16e-04	198	68	5	4139_DN
Drug	Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A	RASA3 KAT6A CASP1 ZMYM2 GAREM1	3.16e-04	198	68	5	6230_UP
Drug	Pralidoxime chloride [51-15-0]; Up 200; 23.2uM; HL60; HT_HG-U133A	SCAPER APC PALLD WIPI2 GAREM1	3.24e-04	199	68	5	3066_UP
Drug	Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A	FN1 ADAMTS9 KAT6A SCAPER CASP1	3.24e-04	199	68	5	3839_UP
Drug	ginsenoside Rh2	HEXA CASP1 CARD16	3.31e-04	45	68	3	CID000119307
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	KLHL21 KAT6A APC BAHD1 GAREM1	3.31e-04	200	68	5	7336_DN
Drug	Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A	FN1 CENPF SCAPER ATP10B CCR7	3.31e-04	200	68	5	6450_UP
Drug	AC1L1G5B	KAT6A CASP1 CARD16	3.53e-04	46	68	3	CID000003531
Drug	CGP 31362	CASP1 CARD16	3.89e-04	10	68	2	CID006540671
Disease	Mental Retardation, Psychosocial	HEXA SCAPER APC ZMYM2 CACNA1G	1.77e-05	139	68	5	C0025363
Disease	Profound Mental Retardation	HEXA SCAPER APC ZMYM2 CACNA1G	1.77e-05	139	68	5	C0020796
Disease	Mental deficiency	HEXA SCAPER APC ZMYM2 CACNA1G	1.77e-05	139	68	5	C0917816
Disease	Intellectual Disability	HEXA BPTF SCAPER APC ZMYM2 CACNA1G TAF6	7.64e-05	447	68	7	C3714756
Disease	guanosine diphosphate measurement	TBC1D4 KCNB2	2.84e-04	11	68	2	EFO_0010494
Disease	coronary thrombosis, GM11992	SCAPER PALLD	6.15e-04	16	68	2	EFO_0001124, EFO_1000883
Disease	facial morphology measurement	DHX15 FAM171A1 EYS PALLD CACNA2D3 RHOT1	7.19e-04	466	68	6	EFO_0007841
Disease	Hypermetropia, Myopia	BPTF TNPO3 CACNA2D3 C2CD5	9.64e-04	189	68	4	HP_0000540, HP_0000545
Disease	susceptibility to rheumatic fever measurement	KCNB2 CACNA2D3	1.90e-03	28	68	2	EFO_0008416

Protein segments in the cluster

Peptide	Gene	Start	Entry
ESRNVTDCCEGYEQL	UMODL1	86	Q5DID0
ENIVVYDVCATIDQC	FAM78B	16	Q5VT40
VCLCQDEVTDDYIGD	CCR7	21	P32248
YQSVCLISEERNECV	DLL4	666	Q9NR61
TIYEDCDCSQELCSE	ARHGEF15	751	O94989
DTLAQCEQEEVYDCS	CD5L	101	O43866
IASCDYNCSNEVLSI	DHX15	576	O43143
QSEAELIDEYVCPQC	BPTF	2901	Q12830
LIDEYVCPQCQSTED	BPTF	2906	Q12830
DTVYTINTENQETCE	ATP10B	936	O94823
YSCEEDSCQVRINTT	MUC5B	5651	Q9HC84
VEDSYLSEETCSNVQ	CHML	436	P26374
CYCTVNLDQEEVFRT	RASA3	36	Q14644
YSTCSLCQEENEDVV	NSUN5	356	Q96P11
NNTDTLYEVVCLESE	RABGAP1	466	Q9Y3P9
ICCSSVDQVNDSVYR	FAM171A1	561	Q5VUB5
VVDFCCEYLEQEVSE	KLHL36	131	Q8N4N3
ECSLTETESNYCTQL	KRT28	331	Q7Z3Y7
YTGINCEINLDECLS	EYS	996	Q5T1H1
DDYSCTEHDECITNQ	NELL2	476	Q99435
NCTLQDCSSLEEYNI	SBF2	616	Q86WG5
DECYCQVVKQITDNT	MYO15A	3111	Q9UKN7
NQYTEIETCVECSAK	RHOT1	136	Q8IXI2
SNSDDEECTCVYEFQ	DCAF10	431	Q5QP82
ECNEDTEVYNITLCT	GAREM1	136	Q9H706
ETSQCQLIYESVIAC	GSTO2	76	Q9H4Y5
TVEEASDNCTQECLI	PCDH11X	1131	Q9BZA7
EEETANQEYKVSSCE	PALLD	951	Q8WX93
CEETLAACQTLQSYT	KAT6A	1446	Q92794
SECDQDYIPETDQDC	ADAMTS9	1276	Q9P2N4
QDCDELVTVDCYNPQ	KLHL21	296	Q9UJP4
DCNTHESLLEVCDDY	KCNB2	66	Q92953
QIEALECAYDNLCQT	ATG7	176	O95352
AQACQICITYICEED	CASP1	66	P29466
TLRDCDQESTCYNTV	CACNA1G	1811	O43497
CSVDEVFCSSLQEEN	CENPF	1521	P49454
SISCDDETVNCYLID	CACNA2D3	846	Q8IZS8
DQCIVDDITYNVNDT	FN1	516	P02751
QDQNSVACIEEKCYV	BAHD1	696	Q8TBE0
EQCVRSYETAENEES	GEN1	851	Q17RS7
EDEDCYILNVQSSSD	GCNA	16	Q96QF7
TNCVTSYLADCETQL	FAAH	111	O00519
EIYVTCESDQSVVEC	SCAPER	116	Q9BY12
VYLCQSENSCLEDSD	PKD1L1	381	Q8TDX9
AQACQICITYICEED	CARD16	66	Q5EG05
VVGYSESTSICEEVC	C2CD5	411	Q86YS7
ESVENYTLTINDDQC	HEXA	111	P06865
QIKVEVYSCCTEESS	RTKN2	171	Q8IZC4
IFCTTDQLEAEIQSC	TARS2	461	Q9BW92
IQEETCQLLTDEVSY	TAF6	31	P49848
CDLECSEQDVETTYF	RNF207	101	Q6ZRF8
ENLQVEASCSVCLEY	TRIM39	21	Q9HCM9
QETCSDLYVTCQVFA	PIK3C3	51	Q8NEB9
IYINESQATECDETQ	NAGPA	211	Q9UK23
QIYECTDTEDVCIVE	WIPI2	66	Q9Y4P8
ESQASDELECKICYN	RNF182	11	Q8N6D2
QETIQTYCVEDTPIC	APC	1256	P25054
DEEEQQYVIKCGTCT	ZNF451	781	Q9Y4E5
TELQLDLESCYAQVC	TMEM102	131	Q8N9M5
VDEALCACEEYLSNL	TTLL3	196	Q9Y4R7
VLQDELQESSYSCED	TBC1D4	1181	O60343
SDCVCSALYAIENVE	TNPO3	246	Q9Y5L0
CEYCQEEKTLHETVN	ZMYM2	681	Q9UBW7
CYDELNQCLTTTQSE	ZNF430	161	Q9H8G1
VECQQCVQEELVYTC	WNT9B	341	O14905
CCVVQEEASPYTLVN	ZYG11A	26	Q6WRX3
VYCQQTLCTSELFED	TERB1	91	Q8NA31
ESTEVECYDSLTACL	TTC9B	131	Q8N6N2
QCLSTVECYNATTNE	KLHL2	461	O95198